title: The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis.
abstract: OBJECTIVE
  The pathogenesis of non-alcoholic steatohepatitis (NASH) is poorly understood. Hepatic iron and copper overload can directly cause lipid peroxidation and eventually hepatic damage. The aim of this study was to investigate the role of hepatic iron and copper accumulation in the development of NASH.
  
  
  METHODS
  Fifty-three patients with NASH were studied. All patients underwent liver biopsy. Clinical and biochemical variables were examined. Serum iron, serum iron binding capacity (SIBC), transferrin saturation, ferritin, ceruloplasmin, and 24-hour urinary copper level were measured. The presence of stainable iron and copper on liver biopsy specimen was investigated.
  
  
  RESULTS
  Serum iron level in 14 (26%) patients, SIBC in 2 (3.7%), ferritin level in 1 (1.9%) and transferrin saturation in 2 (3.7%) patients were elevated. One male patient had abnormality in serum iron metabolism showing the possibility of hemochromatosis. Slightly decreased serum ceruloplasmin level in 4 (7.5%) patients and slightly elevated 24-hour urinary copper amount in 6 (11%) patients were identified. No patients had the abnormality showing the possibility of Wilson disease. NASH was grade I in 25 (47%) patients, grade II in 20 (38%) and grade III in 8 (15%). Fourteen (26%) patients had no fibrosis, 31 (59%) patients had mild fibrosis. None of the patients had bridging or septal fibrosis or cirrhosis. No hepatic iron or copper staining was demonstrated in any patient.
  
  
  CONCLUSIONS
  There was no correlation between hepatic iron and copper accumulation and the development of NASH.
authors.affiliation: Ankara University Medical School, Department of Gastroenterology, Ankara, Turkey.
authors.forename: Kemal
authors.initials: K
authors.lastname: Akin
authors.forename: Ali Reşit
authors.initials: AR
authors.lastname: Beyler
authors.forename: Muhsin
authors.initials: M
authors.lastname: Kaya
authors.forename: Esra
authors.initials: E
authors.lastname: Erden
mesh_terms: D000328:Adult; D001706:Biopsy; D003300:Copper / Q000378:metabolism*; D005234:Fatty Liver / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D005260:Female; D006505:Hepatitis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012720:Severity of Illness Index
chemical_list: D003300:Copper; D007501:Iron